Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity
- 4 May 2022
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 54 (7) , 1521-1527
Abstract
Purpose to compare observed overall survival vs age-adjusted lifetable (LT) derived life expectancy (LE) in metastatic urothelial bladder cancer (MBCa) patients according to race/ethnicity. Methods We identified Caucasian, African American, Hispanic/Latino and Asian metastatic urothelial bladder cancer patients from 2004 to 2011 within the Surveillance, Epidemiology and End Results database. Social Security Administration tables were used to compute 5 year LE. LT-derived LE was compared to observed overall survival OS. Additionally, we relied on Poisson regression plots to display cancer-specific mortality (CSM) relative to other-cause mortality (OCM) for each race/ethnicity. Results Overall, 2286 MBCa patients were identified. Of those, 1800 (79%) were Caucasian vs 212 (9.3%) African American vs 189 (8.3%) Hispanic/Latino vs 85 (3.7%) Asians. The median age at diagnosis was 71 years for Asians vs 70 for Caucasians vs 67 for Hispanic/Latinos vs 67 for African Americans. African Americans showed the biggest difference between observed OS and LT-predicted LE at five years (− 83.8%), followed by Hispanic/Latinos (− 81%), Caucasians (− 77%) and Asian patients (− 69%). In Poisson regression plots, Hispanic/Latinos displayed the highest cancer-specific mortality rate (88%), while African/Americans showed the highest other cause mortality rate (12%). Conversely, Asian patients displayed the lowest CSM rate (83%) and second lowest OCM rate (7%). Conclusions African Americans showed the least favorable survival profile in MBCa, despite being youngest at diagnosis. Contrarily, Asians displayed the best survival profile in MBCa, despite being oldest at diagnosis.Keywords
This publication has 26 references indexed in Scilit:
- Competing risks analyses: objectives and approachesEuropean Heart Journal, 2014
- Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysisCancer Epidemiology, 2013
- Ethnicity and Smoking Status are Associated with Awareness of Smoking Related Genitourinary DiseasesJournal of Urology, 2012
- Disparities in bladder cancerUrologic Oncology: Seminars and Original Investigations, 2012
- Transitional Cell Carcinoma of the Bladder: Racial and Gender Disparities in Survival (1993 to 2002), Stage and Grade (1993 to 2007)Journal of Urology, 2011
- Racial differences in treatment and outcomes among patients with early stage bladder cancerCancer, 2009
- Bladder cancerThe Lancet, 2009
- Sex and racial differences in bladder cancer presentation and mortality in the USCancer, 2008
- Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyJournal of Clinical Oncology, 2000
- The Latino mortality paradox: a test of the "salmon bias" and healthy migrant hypotheses.American Journal of Public Health, 1999